FDA In Brief: FDA issues alert on potential premature battery depletion of certain Medtronic implantable pacemakers, approves related enhancements to device

FDA In Brief: FDA issues alert on potential premature battery depletion of certain Medtronic implantable pacemakers, approves related enhancements to device

Today, the U.S. Food and Drug Administration issued a safety communication to inform patients and health care professionals about the potential for the batteries of certain Medtronic implantable pacemakers to drain more quickly than expected and without warning to patients. Implanted pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) are battery-powered devices that provide pacing for slow heart rhythms and heart failure. If a capacitor – one of the electronic components of these devices – is cracked it may lose functionality and create an electric short, which can

Read More